Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Yu Jonathan Yen-Wen, holds the title of Chief Operating Officer at Disc Medicine, Inc..
On 2026-06-26, the insider transacted 600 shares.The shares were transacted at a weighted average price of $43.00 per share, resulting in a total market-relevant value of $26K.
Yu Jonathan Yen-Wen (Chief Operating Officer) sold $26K of $IRON
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.